
zzso fatty liver disease is now recognized as the most common liver disease in the United States, with a prevalence of approximately zzso in the general population and up to zzso to zzso in patients with obesity and type II diabetes zzso zzso fatty liver disease is a zzso syndrome with a wide spectrum of zzso abnormalities and clinical zzso zzso zzso has a benign clinical zzso In contrast, zzso zzso zzso may progress to zzso and zzso death in zzso and zzso of patients, zzso Cases occur most commonly in obese, middle-aged women with zzso However, NASH may also occur in children and zzso men with normal zzso and zzso zzso The zzso involves two zzso The first is insulin resistance, which causes zzso The second is zzso stress, which produces zzso zzso and activates inflammatory zzso resulting in zzso Liver biopsy provides zzso information and identifies NASH patients who may benefit from zzso Treatment consists of managing the zzso zzso diabetes, and zzso Although zzso therapy with vitamin E is often used, zzso acid is the only drug that has shown benefit and is the most promising of the drugs currently being zzso Future therapies will depend on a greater understanding of the zzso and should focus on diminishing zzso 

